85
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Renal Function and Risk Factors of Moderate to Severe Chronic Kidney Disease in Golestan Province, Northeast of Iran

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          The incidence of end-stage renal disease is increasing worldwide. Earlier studies reported high prevalence rates of obesity and hypertension, two major risk factors of chronic kidney disease (CKD), in Golestan Province, Iran. We aimed to investigate prevalence of moderate to severe CKD and its risk factors in the region.

          Methods

          Questionnaire data and blood samples were collected from 3591 participants (≥18 years old) from the general population. Based on serum creatinine levels, glomerular filtration rate (GFR) was estimated.

          Results

          High body mass index (BMI) was common: 35.0% of participants were overweight (BMI 25–29.9) and 24.5% were obese (BMI ≥30). Prevalence of CKD stages 3 to 5 (CKD S3-5), i.e., GFR <60 mL/min/1.73 m 2, was 4.6%. The odds ratio (OR) and 95% confidence interval (95% CI) for the risk of CKD S3-5 associated with every year increase in age was 1.13 (1.11–1.15). Men were at lower risk of CKD S3-5 than women (OR = 0.28; 95% CI 0.18–0.45). Obesity (OR = 1.78; 95% CI 1.04–3.05) and self-reported diabetes (OR = 1.70; 95% CI 1.00–2.86), hypertension (OR = 3.16; 95% CI 2.02–4.95), ischemic heart disease (OR = 2.73; 95% CI 1.55–4.81), and myocardial infarction (OR = 2.69; 95% CI 1.14–6.32) were associated with increased risk of CKD S3-5 in the models adjusted for age and sex. The association persisted for self-reported hypertension even after adjustments for BMI and history of diabetes (OR = 2.85; 95% CI 1.77–4.59).

          Conclusion

          A considerable proportion of inhabitants in Golestan have CKD S3-5. Screening of individuals with major risk factors of CKD, in order to early detection and treatment of impaired renal function, may be plausible. Further studies on optimal risk prediction of future end-stage renal disease and effectiveness of any screening program are warranted.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: not found
          • Article: not found

          Chronic kidney disease in the developing world.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.

              Equations using serum creatinine level, age, sex, and other patient characteristics often are used to estimate glomerular filtration rate (GFR) in both clinical practice and research studies. However, the critical dependence of these equations on serum creatinine assay calibration often is overlooked, and the reproducibility of estimated GFR is rarely discussed. We address these issues in frozen samples from 212 Modification of Diet in Renal Disease (MDRD) study participants and 342 Third National Health and Nutrition Examination Survey (NHANES III) participants assayed for serum creatinine level a second time during November 2000. Variation in serum creatinine level was assessed in 1,919 NHANES III participants who had serum creatinine measured on two visits a median of 17 days apart. Linear regression was used to compare estimates. Calibration of serum creatinine varied substantially across laboratories and time. Data indicate that serum creatinine assays on the same samples were 0.23 mg/dL higher in the NHANES III than MDRD study. Data from the College of American Pathologists suggest that a difference of this magnitude across laboratories is not unusual. Conversely, serum creatinine assays an average of 2 weeks apart have better precision (SD of percentage of difference in estimated GFR, 15%; 90% of estimates within 21%). Errors in calibration make little difference in estimating severely decreased GFR (<30 mL/min/1.73 m2), but result in progressively larger differences at higher GFRs. Both clinical and research use of serum creatinine or equations to estimate GFR require knowledge of the calibration of the serum creatinine assay. Copyright 2002 by the National Kidney Foundation, Inc.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, USA )
                1932-6203
                2010
                3 December 2010
                : 5
                : 12
                : e14216
                Affiliations
                [1 ]Nephrology Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
                [2 ]Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
                [3 ]International Agency for Research on Cancer, Lyon, France
                [4 ]Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
                [5 ]School of Public Health, Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran
                [6 ]Clinical Science Study Group Iran, IR of Iran Academy of Medical Sciences, Tehran, Iran
                [7 ]Endocrinology and Metabolism Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
                Kenya Medical Research Institute, Kenya
                Author notes

                Conceived and designed the experiments: IN RS FM RS MYG BB ANH BL RM. Performed the experiments: IN RS FM RS MYG BB ANH BL RM. Analyzed the data: FI RS MYG MH. Contributed reagents/materials/analysis tools: IN FA FI RS FM RS MH RM. Wrote the paper: IN FA FI RS MH BB ANH BL RM.

                Article
                10-PONE-RA-20921R1
                10.1371/journal.pone.0014216
                2997063
                21151983
                d37ec4c8-6379-49e6-88e5-d88f9088373b
                Najafi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
                History
                : 5 July 2010
                : 29 October 2010
                Page count
                Pages: 6
                Categories
                Research Article
                Nephrology/Chronic Kidney Disease
                Public Health and Epidemiology/Epidemiology
                Public Health and Epidemiology/Health Policy

                Uncategorized
                Uncategorized

                Comments

                Comment on this article